Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing...more
7/17/2024
/ Ambulatory Surgery Centers ,
Digital Health ,
Health Care Providers ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Investment ,
Investment Partnerships ,
Investors ,
Managed Care Contracts ,
Medical Research ,
Pharmaceutical Industry ,
PHI ,
Popular ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
The 42nd annual J.P. Morgan Healthcare Conference started with clear skies and overall optimism from investors. But with Jamie Dimon’s prediction of a recession in 2024 on Tuesday morning, the climate shifted to an on-again,...more
1/12/2024
/ Acquisitions ,
Asset Diversification ,
Chapter 11 ,
Health Technology ,
Healthcare ,
Home Health Care ,
Hospice ,
Initial Public Offering (IPO) ,
Investors ,
JPMorgan Chase ,
Medicaid ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Reimbursements ,
Takeovers ,
Value-Based Care
With some exceptions, healthcare M&A activity is down this year compared to the record-breaking highs of 2021. Those exceptions include the hospital sector, which is still seeing fewer but significantly larger (i.e., billion...more
8/17/2022
/ Acquisitions ,
Ambulatory Surgery Centers ,
Dental Practice ,
Digital Health ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Life Sciences ,
Managed Care Contracts ,
Mental Health ,
Mergers ,
Pharmacies ,
Physicians